1Costello JF,et al.Silencing of p16 CKDN2 expression in human gliomas by methylation and chromatin condensation[].Cancer Research.1996
2Loda M,et al.p53 gene expression in medulloblastoma by qualitative polymerase chain reaction[].Diagnostic Molecular Pathology.1992
3Adesina AM,et al.p53 mutation and MDM2 gene amplification are uncommon in medulloblastoma[].Cancer Research.1994
4Ohgaki,et al.p53 mutations in nonastrocytic human brain tumors[].Cancer Research.1992
同被引文献7
1Schiffer D, Cavalla P, Migheli A, et al. Bcl-2 distribution in neuroepithelial tumors:an immunohistochemical study[J]. J Neurooncol, 1996,27(2):101-109.
2Krajewski S, Krajewska M, Ehrmann J, et al. Immunohistochemical analysis of Bcl-2,Bcl-x,Mcl-1, and Bax in tumors of central and peripheral nervons system origin[J]. Am J Pathol ,1997,150:805-814.
3Nakasu S, Nakasu Y, Nioka H, et al. Bcl-2 protein expression in tumor of the central nervous system[J]. Acta Neurpathol, 1994,88(6):520-526.
4Loda M. P53 gene expression in medulloblastoma by qualitative polymerase chain reaction[J]. Diagn MoL Pathol,1992,1:36.
5Amold J L. P53, the cellular gatekeeper for growth and division[J]. Cell ,1997,88:323-333.
6Katsetos C D,Krishna L,Frankfurter A, et al. Acytomorphological Scheme of differentiating neuronal phenotypes in cerbellar medulloblastomas based on immunolocalization of class Ⅲ Beta-tabulin isotyp(beta Ⅲ) and proliferating cell nuclear antigen (PCNA)/cyclin[J]. Clin Neuropathol,1995,14(2):72.
